PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) Stock Fundamental Analysis

EPA:ALPAT • FR0010785790

8.34 EUR
+0.08 (+0.97%)
Last: Feb 25, 2026, 07:00 PM
Fundamental Rating

3

Taking everything into account, ALPAT scores 3 out of 10 in our fundamental rating. ALPAT was compared to 77 industry peers in the Biotechnology industry. ALPAT has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALPAT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ALPAT had positive earnings in the past year.
  • The reported net income has been mixed in the past 5 years: ALPAT reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: ALPAT reported negative operating cash flow in multiple years.
ALPAT.PA Yearly Net Income VS EBIT VS OCF VS FCFALPAT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

  • The Return On Assets of ALPAT (2.00%) is better than 77.92% of its industry peers.
  • ALPAT's Return On Equity of 3.43% is amongst the best of the industry. ALPAT outperforms 80.52% of its industry peers.
Industry RankSector Rank
ROA 2%
ROE 3.43%
ROIC N/A
ROA(3y)1.25%
ROA(5y)-1.47%
ROE(3y)2.03%
ROE(5y)-3.1%
ROIC(3y)N/A
ROIC(5y)N/A
ALPAT.PA Yearly ROA, ROE, ROICALPAT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

  • ALPAT has a Profit Margin of 34.16%. This is amongst the best in the industry. ALPAT outperforms 89.61% of its industry peers.
  • With an excellent Gross Margin value of 145.40%, ALPAT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALPAT has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 34.16%
GM 145.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
ALPAT.PA Yearly Profit, Operating, Gross MarginsALPAT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1

2. Health

2.1 Basic Checks

  • ALPAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALPAT has been increased compared to 1 year ago.
  • Compared to 5 years ago, ALPAT has more shares outstanding
  • The debt/assets ratio for ALPAT has been reduced compared to a year ago.
ALPAT.PA Yearly Shares OutstandingALPAT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALPAT.PA Yearly Total Debt VS Total AssetsALPAT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of 0.54, we must say that ALPAT is in the distress zone and has some risk of bankruptcy.
  • ALPAT has a Altman-Z score of 0.54. This is comparable to the rest of the industry: ALPAT outperforms 59.74% of its industry peers.
  • ALPAT has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.40, ALPAT is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACCN/A
WACC6.84%
ALPAT.PA Yearly LT Debt VS Equity VS FCFALPAT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

  • A Current Ratio of 0.88 indicates that ALPAT may have some problems paying its short term obligations.
  • The Current ratio of ALPAT (0.88) is worse than 68.83% of its industry peers.
  • A Quick Ratio of 0.31 indicates that ALPAT may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.31, ALPAT is not doing good in the industry: 89.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.31
ALPAT.PA Yearly Current Assets VS Current LiabilitesALPAT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

5

3. Growth

3.1 Past

  • The earnings per share for ALPAT have decreased strongly by -73.00% in the last year.
  • Looking at the last year, ALPAT shows a very negative growth in Revenue. The Revenue has decreased by -63.00% in the last year.
  • ALPAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.44% yearly.
EPS 1Y (TTM)-73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-135.71%
Revenue 1Y (TTM)-63%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-86.85%

3.2 Future

  • Based on estimates for the next years, ALPAT will show a very strong growth in Earnings Per Share. The EPS will grow by 68.40% on average per year.
  • Based on estimates for the next years, ALPAT will show a very strong growth in Revenue. The Revenue will grow by 31.88% on average per year.
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALPAT.PA Yearly Revenue VS EstimatesALPAT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1M 2M 3M 4M
ALPAT.PA Yearly EPS VS EstimatesALPAT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5 -2

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 30.89, ALPAT can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, ALPAT is valued cheaper than 81.82% of the companies in the same industry.
  • ALPAT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.05.
  • Based on the Price/Forward Earnings ratio of 14.46, the valuation of ALPAT can be described as correct.
  • ALPAT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALPAT is cheaper than 96.10% of the companies in the same industry.
  • ALPAT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.89
Fwd PE 14.46
ALPAT.PA Price Earnings VS Forward Price EarningsALPAT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALPAT indicates a somewhat cheap valuation: ALPAT is cheaper than 79.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 54.34
ALPAT.PA Per share dataALPAT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALPAT's earnings are expected to grow with 68.40% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y68.4%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • ALPAT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PLANT ADVANCED TECHNOLOGIES

EPA:ALPAT (2/25/2026, 7:00:00 PM)

8.34

+0.08 (+0.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-29
Earnings (Next)03-01
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners33.62%
Ins Owner ChangeN/A
Market Cap9.34M
Revenue(TTM)936.80K
Net Income(TTM)320.00K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 30.89
Fwd PE 14.46
P/S 9.97
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 1.52
EV/EBITDA 54.34
EPS(TTM)0.27
EY3.24%
EPS(NY)0.58
Fwd EY6.92%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.84
BVpS8.71
TBVpS5.47
PEG (NY)0.32
PEG (5Y)N/A
Graham Number7.27
Profitability
Industry RankSector Rank
ROA 2%
ROE 3.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 34.16%
GM 145.4%
FCFM N/A
ROA(3y)1.25%
ROA(5y)-1.47%
ROE(3y)2.03%
ROE(5y)-3.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 15.63
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.31
Altman-Z 0.54
F-ScoreN/A
WACC6.84%
ROIC/WACCN/A
Cap/Depr(3y)108.69%
Cap/Depr(5y)137.67%
Cap/Sales(3y)44.33%
Cap/Sales(5y)66.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-135.71%
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-63%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-86.85%
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-188.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.14%
OCF growth 3YN/A
OCF growth 5YN/A

PLANT ADVANCED TECHNOLOGIES / ALPAT.PA FAQ

Can you provide the ChartMill fundamental rating for PLANT ADVANCED TECHNOLOGIES?

ChartMill assigns a fundamental rating of 3 / 10 to ALPAT.PA.


What is the valuation status for ALPAT stock?

ChartMill assigns a valuation rating of 5 / 10 to PLANT ADVANCED TECHNOLOGIES (ALPAT.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for PLANT ADVANCED TECHNOLOGIES?

PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) has a profitability rating of 4 / 10.


What is the financial health of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) stock?

The financial health rating of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) is 1 / 10.